{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:30Z","timestamp":1791405450203,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Backgroud<\/jats:title>\n                <jats:p>Primary tonsil diffuse large B cell lymphoma (PT-DLBCL) is an uncommon disease entity. The role of radiation therapy (RT) in PT-DLBCL is debatable in both the pre- and post- rituximab era. The purpose of this study was to evaluate the treatment outcome and establish a prognostic model in PT-DLBCL based on the Surveillance, Epidemiology, and End Results (SEER) database.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Data of 1214 PT-DLBCL patients diagnosed between 1975 and 2016 were extracted from SEER 18. The effect of RT was assessed for the entire cohort and subgroups by stages using univariate, multivariate Cox regression analyses and propensity score matching (PSM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The entire cohort included 1043 patients with early-stage (ES) PT-DLBCL and 171 patients with advanced-stage (AS) disease. A decreasing trend of RT utilization in the ES cohort after 2002 was observed. 47.4% of patients in ES received RT, whereas 25.1% in AS underwent RT. RT significantly improved overall survival in both univariate (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and multivariate (<jats:italic>P<\/jats:italic>\u2009=\u20090.002) analyses. PSM analysis further validated the survival advantage of RT (<jats:italic>P<\/jats:italic>\u2009=\u20090.002). A nomogram was established to predict the potential survival benefit. Subgroup analysis revealed RT was significantly associated with overall survival in ES patients of PT-DLBCL (<jats:italic>P<\/jats:italic>\u2009=\u20090.001) and in the rituximab era (<jats:italic>P<\/jats:italic>\u2009=\u20090.001) but not in those with AS disease (<jats:italic>P<\/jats:italic>\u2009=\u20090.241).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This population-based study encloses the largest sample of PT-DLBCL to date and demonstrates a favorable survival role of RT in early stages rather than advanced stages. The established nomogram helps to identify high risk patients to improve prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01919-x","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:08:03Z","timestamp":1633356483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Jing","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3904\/kjim.2014.29.3.352","volume":"29","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, Suh CW, Lee SI, Kim WS, Lee WS, Kim HJ, et al. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer\u2019s ring: nationwide Korean study. Korean J Intern Med. 2014;29:352\u201360.","journal-title":"Korean J Intern Med"},{"key":"1919_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0360-3016(85)90158-0","volume":"11","author":"C Jacobs","year":"1985","unstructured":"Jacobs C, Hoppe RT. Non-Hodgkin\u2019s lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys. 1985;11:357\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0964-1955(95)00058-5","volume":"32b","author":"A Avil\u00e9s","year":"1996","unstructured":"Avil\u00e9s A, Delgado S, Ruiz H, de la Torre A, Guzman R, Talavera A. Treatment of non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer Part B Oral Oncol. 1996;32b:19\u201323.","journal-title":"Eur J Cancer Part B Oral Oncol"},{"key":"1919_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/1097-0142(19850701)56:1<157::AID-CNCR2820560125>3.0.CO;2-X","volume":"56","author":"SH Saul","year":"1985","unstructured":"Saul SH, Kapadia SB. Primary lymphoma of Waldeyer\u2019s ring. Clinicopathologic study of 68 cases. Cancer. 1985;56:157\u201366.","journal-title":"Cancer"},{"key":"1919_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1919_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3109\/02841869309092451","volume":"32","author":"M Uematsu","year":"1993","unstructured":"Uematsu M, Kondo M, Hiramatsu H, Ikeda Y, Mikata S, Katayama M, et al. Stage IA non-Hodgkin\u2019s lymphoma of the Waldeyer\u2019s ring. Limited chemotherapy and radiation therapy versus radiation therapy alone. Acta Oncol (Stockholm Sweden). 1993;32:675\u20138.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"key":"1919_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/oxfordjournals.annonc.a058129","volume":"3","author":"T Takagi","year":"1992","unstructured":"Takagi T, Sampi K, Iida K. Stage I malignant lymphoma of Waldeyer\u2019s ring: frequent relapse after radiation therapy. Ann Oncol Off J Eur Soc Med Oncol. 1992;3:137\u20139.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"1919_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/cncr.22841","volume":"110","author":"S Laskar","year":"2007","unstructured":"Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, et al. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required? Cancer. 2007;110:816\u201323.","journal-title":"Cancer"},{"key":"1919_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/10428194.2012.710907","volume":"54","author":"M Mian","year":"2013","unstructured":"Mian M, Ferreri AJ, Rossi A, Conconi A, Tsang R, Gospodarowicz MK, et al. Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer\u2019s ring in remission after anthracycline-containing chemotherapy. Leukemia lymphoma. 2013;54:62\u20138.","journal-title":"Leukemia lymphoma"},{"key":"1919_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235\u201342.","journal-title":"N Engl J Med"},{"key":"1919_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.leukres.2018.09.011","volume":"74","author":"C Li","year":"2018","unstructured":"Li C, Ma X, Pan Z, Lv F, Xia Z, Xue K, et al. Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer\u2019s ring in remission after R-CHOP immunochemotherapy. Leukemia Res. 2018;74:80\u20135.","journal-title":"Leukemia Res"},{"key":"1919_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fonc.2020.01093","volume":"10","author":"J Wang","year":"2020","unstructured":"Wang J, Zhou M, Zhou R, Xu J, Chen B. Nomogram for predicting the overall survival of adult patients with primary gastrointestinal diffuse large B cell lymphoma: a SEER-based study. Front Oncol. 2020;10:1093.","journal-title":"Front Oncol"},{"key":"1919_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3389\/fonc.2020.01157","volume":"10","author":"S Ma","year":"2020","unstructured":"Ma S, Zhang Y, Li Z, Yan H, Xia L, Shi W, et al. Role of radiation therapy differs between stages in primary bone large B-cell lymphoma in rituximab era: a population-based analysis. Front Oncol. 2020;10:1157.","journal-title":"Front Oncol"},{"key":"1919_CR14","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1002\/cncr.28146","volume":"119","author":"MD Galsky","year":"2013","unstructured":"Galsky MD, Moshier E, Krege S, Lin CC, Hahn N, Ecke T, et al. Nomogram for predicting survival in patients with unresectable and\/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy. Cancer. 2013;119:3012\u20139.","journal-title":"Cancer"},{"key":"1919_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361\u201387.","journal-title":"Stat Med"},{"key":"1919_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0046-8177(03)00086-8","volume":"34","author":"HJ Ree","year":"2003","unstructured":"Ree HJ, Ohsima K, Aozasa K, Takeuchi K, Kim CW, Yang WI, et al. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil. Hum Pathol. 2003;34:610\u20136.","journal-title":"Hum Pathol"},{"key":"1919_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1053\/hupa.2002.125371","volume":"33","author":"HJ Ree","year":"2002","unstructured":"Ree HJ, Kikuchi M, Lee SS, Ohshima K, Yang WI, Ko YH, et al. Focal follicular features in tonsillar diffuse large B-cell lymphomas: follicular lymphoma with diffuse areas or follicular colonization. Hum Pathol. 2002;33:732\u201340.","journal-title":"Hum Pathol"},{"key":"1919_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3109\/10428190109097720","volume":"42","author":"AD Krol","year":"2001","unstructured":"Krol AD, Le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noorduk EM. Waldeyer\u2019s ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry. Leukemia lymphoma. 2001;42:1005\u201313.","journal-title":"Leukemia lymphoma"},{"key":"1919_CR19","first-page":"652682","volume":"2012","author":"M Marques","year":"2012","unstructured":"Marques M, Luz E, Hummel M, Vieira M, Bahia RC, Oliveira MC, et al. Prognostic biomarkers and EBV infection research in diffuse large B-cell lymphoma of the palatine tonsils. ISRN Oncol. 2012;2012:652682.","journal-title":"ISRN Oncol"},{"key":"1919_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM199807023390104","volume":"339","author":"TP Miller","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma. N Engl J Med. 1998;339:21\u20136.","journal-title":"N Engl J Med"},{"key":"1919_CR21","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","volume":"22","author":"SJ Horning","year":"2004","unstructured":"Horning SJ, Weller E, Kim K, Earle JD, O\u2019Connell MJ, Habermann TM, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin\u2019s lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22:3032\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1919_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1056\/NEJMoa042040","volume":"352","author":"F Reyes","year":"2005","unstructured":"Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005;352:1197\u2013205.","journal-title":"N Engl J Med"},{"key":"1919_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.2006.07.0722","volume":"25","author":"C Bonnet","year":"2007","unstructured":"Bonnet C, Fillet G, Mounier N, Ganem G, Molina TJ, Thi\u00e9blemont C, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:787\u201392.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1919_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hed.1077","volume":"23","author":"AA Ezzat","year":"2001","unstructured":"Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, et al. Localized non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: clinical features, management, and prognosis of 130 adult patients. Head Neck. 2001;23:547\u201358.","journal-title":"Head Neck"},{"key":"1919_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1470-2045(08)70078-0","volume":"9","author":"M Pfreundschuh","year":"2008","unstructured":"Pfreundschuh M, Ho AD, Cavallin-Stahl E, Wolf M, Pettengell R, Vasova I, et al. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study. Lancet Oncol. 2008;9:435\u201344.","journal-title":"Lancet Oncol"},{"key":"1919_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","volume":"32","author":"G Held","year":"2014","unstructured":"Held G, Murawski N, Ziepert M, Fleckenstein J, P\u00f6schel V, Zwick C, et al. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32:1112\u20138.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1919_CR27","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2009.27.3441","volume":"28","author":"J Phan","year":"2010","unstructured":"Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28:4170\u20136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1919_CR28","unstructured":"Rituximab. and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell NonHodgkin\u2019s Lymphoma [http:\/\/www.clinicaltrials.gov\/ct2\/show\/record\/NCT00278408?term = NCT00278408&rank = 1.]."},{"key":"1919_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/COC.0000000000000215","volume":"38","author":"BS Dabaja","year":"2015","unstructured":"Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, et al. ACR appropriateness criteria\u00ae diffuse large B-cell lymphoma. Am J Clin Oncol. 2015;38:610\u201320.","journal-title":"Am J Clin Oncol"},{"key":"1919_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3857\/roj.2016.01781","volume":"34","author":"YH Lee","year":"2016","unstructured":"Lee YH, Cho SG, Jung SE, Kim SH, O JH, Park GS, et al. Analysis of treatment outcomes for primary tonsillar lymphoma. Radiat Oncol J. 2016;34:273\u20139.","journal-title":"Radiat Oncol J"},{"key":"1919_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0360-3016(99)00051-6","volume":"44","author":"SS Kamath","year":"1999","unstructured":"Kamath SS, Marcus RB Jr, Lynch JW, Mendenhall NP. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys. 1999;44:563\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2011;100:86\u201392.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1919_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92:11\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clon.2012.07.011","volume":"25","author":"PJ Hoskin","year":"2013","unstructured":"Hoskin PJ, D\u00edez P, Williams M, Lucraft H, Bayne M. Recommendations for the use of radiotherapy in nodal lymphoma. Clin Oncol (R Coll Radiol (G B)). 2013;25:49\u201358.","journal-title":"Clin Oncol (R Coll Radiol (G B))"},{"key":"1919_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2014;89:49\u201358.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1182\/blood.2020005846","volume":"137","author":"CL Freeman","year":"2021","unstructured":"Freeman CL, Savage KJ, Villa DR, Scott DW, Srour L, Gerrie AS, et al. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2021;137:929\u201338.","journal-title":"Blood"},{"key":"1919_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1182\/blood-2017-07-793984","volume":"131","author":"T Lamy","year":"2018","unstructured":"Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, et al. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood. 2018;131:174\u201381.","journal-title":"Blood"},{"key":"1919_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/joim.12813","volume":"284","author":"TC El-Galaly","year":"2018","unstructured":"El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY. FDG-PET\/CT in the management of lymphomas: current status and future directions. J Internal Med. 2018;284:358\u201376.","journal-title":"J Internal Med"},{"key":"1919_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00277-004-0860-0","volume":"84","author":"M Mohammadianpanah","year":"2005","unstructured":"Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Treatment results of tonsillar lymphoma: a 10-year experience. Ann Hematol. 2005;84:223\u20136.","journal-title":"Ann Hematol"},{"key":"1919_CR40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683\u201390.","journal-title":"Ann Surg Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01919-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:15:20Z","timestamp":1633356920000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01919-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient consent for this retrospective study was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is approved by all authors for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"193"}}